Hemab Therapeutics Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COAG and other ETFs, options, and stocks.About COAG
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience.
CEOBenny Sorensen
CEOBenny Sorensen
Employees72
Employees72
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2020
Founded2020
Employees72
Employees72
COAG Key Statistics
Market cap53.93M
Market cap53.93M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today$31.81
High today$31.81
Low today$27.00
Low today$27.00
Open price$27.00
Open price$27.00
Volume791.88K
Volume791.88K
52 Week high—
52 Week high—
52 Week low—
52 Week low—
Stock Snapshot
The current Hemab Therapeutics Holdings(COAG) stock price is $30.26, with a market capitalization of 53.93M.
During the trading session on 2026-05-01, Hemab Therapeutics Holdings(COAG) shares reached a daily high of $31.81 and a low of $27.00. At a current price of $30.26, the stock is +12.1% higher than the low and still -4.9% under the high.
Trading activity shows a volume of 791.88K.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.